Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 7/20 | 0.52 |
| ▸ | PDE5A | O76074 | 9/20 | 0.48 |
| ▸ | PDE2A | O00408 | 1/20 | 0.46 |
| ▸ | PDE8A | O60658 | 1/20 | 0.46 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.46 |
| ▸ | PDE11A | Q9HCR9 | 1/20 | 0.46 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.46 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.46 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.44 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.44 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12321567 | 0.86 | PDE5A (0.53) | PDE4APDE5APDE2APDE8APDE3B | |
| SCHEMBL2362657 | 0.86 | PDE5A (0.52) | PDE4APDE5APDE2APDE8APDE3B | |
| SCHEMBL2416980 | 0.85 | PDE4A (0.58) | PDE4APDE5APDE2APDE8APDE3B | |
| SCHEMBL2362351 | 0.76 | PDE5A (0.49) | PDE4APDE5APDE4BPDE4CPDE4D | |
| SCHEMBL16557132 | 0.75 | PDE4A (0.70) | PDE4APDE5APDE2APDE8APDE3B | |
| SCHEMBL2361465 | 0.72 | PDE4A (0.60) | PDE4APDE5APDE2APDE8APDE3B | |
| SCHEMBL2362440 | 0.72 | PDE4A (0.64) | PDE4APDE5APDE2APDE8APDE3B | |
| SCHEMBL12282389 | 0.72 | PDE4A (0.57) | PDE4APDE5APDE2APDE8APDE3B | |
| SCHEMBL7522047 | 0.72 | PDE4A (0.67) | PDE4APDE5APDE2APDE8APDE3B | |
| SCHEMBL2417050 | 0.71 | PDE4A (0.73) | PDE4APDE5APDE2APDE8APDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9763948-B2 | PDE1 inhibitory compounds and methods | INTRA-CELLULAR THERAPIES, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| US-9763948-B2 | PDE1 inhibitory compounds and methods | INTRA-CELLULAR THERAPIES, INC. (US) | 2017-09-19 | — | — | US | disclosed |
| EP-2576551-A1 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| WO-2011153138-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2011-12-08 | — | — | WO | disclosed |
| WO-2011153138-A1 | ORGANIC COMPOUNDS | INTRA-CELLULAR THERAPIES, INC. (US) | 2011-12-08 | — | — | WO | disclosed |